CTRI/2024/01/061326尚未招募4 期
COMPARING CLINICAL EFFICACY OF SILYMARIN WITH THAT OF A STANDARD THERAPEUTIC COMBINATION OF LYCOPENE, ALPHA LIPOIC ACID AND TOCOPHEROL IN THE MANAGEMENT OF ORAL SUBMUCOUS FIBROSIS-A RANDOMIZED CLINICAL TRIAL - NI
KAKARLA VENKATA SUSMITHA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Clinically diagnosed OSMF ( stage 1,2 & 3 as per the criteria put forward by the Tinky Bose and Anitha Balan.
- •Patients who are ready to quit the habit
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
3 期
The effect of silymarin on serum liver enzyme level in patients with traumaIRCT20190911044744N1Shiraz University of Medical Sciences90
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60